Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Predictive Oncology Initiates $2.2M Direct Stock Offering

Predictive Oncology Initiates $2.2M Direct Stock Offering

May 07, 2020
|
staff reporter

NEW YORK – Predictive Oncology said Thursday that it has agreed to a direct offering of 1,396,826 shares at $1.575 per share, for gross proceeds of about $2.2 million.  

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Jun
04
Featured Webinar

COVID-19 Testing, Treatment and Future Outlook

Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

What's Popular?

In Cancer

  1. Germline Results From Tumor-Normal Sequencing Guides Precision Therapy in Advanced Cancer Patients

  2. Oncologists Make Progress Toward Showing Utility for Brain Cancer Liquid Biopsy

  3. Oncotype DX May Be Helpful in Guiding Neoadjuvant Breast Cancer Treatment Decisions

    Premium

  4. Polygenic Risk Score, Family History Refine Breast Cancer Risk Assessment in CHEK2 Mutation Carriers

  5. Pediatric Precision Oncology Study Matches 28 Percent of Patients to Targeted Therapies

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.